SCHEMBL8838342

SCHEMBL8838342

CC(=O)OC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
GRM8 O00222 1/20 0.54
GRM6 O15303 1/20 0.54
GRIN2D O15399 1/20 0.54
GRIN3B O60391 1/20 0.54
GSR P00390 1/20 0.54
GRIK1 P39086 1/20 0.54
GRM5 P41594 1/20 0.54
GRIA1 P42261 1/20 0.54
GRIA2 P42262 1/20 0.54
GRIA3 P42263 1/20 0.54
SLC1A3 P43003 1/20 0.54
SLC1A2 P43004 1/20 0.54
SLC1A1 P43005 1/20 0.54
GRIA4 P48058 1/20 0.54
GRIN1 Q05586 1/20 0.54
GRIN2A Q12879 1/20 0.54
GRIK2 Q13002 1/20 0.54
GRIK3 Q13003 1/20 0.54
GRIN2B Q13224 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23200441 1.00 CYP1A2 (0.54) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL4959221 0.87 GRM8 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL496858 0.87 GRM8 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL28289202 0.86 GRM8 (0.58) CYP1A2GRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL10636419 0.85 GRM8 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL12477334 0.85 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL12477330 0.85 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
Cetostearyl Alcohol SCHEMBL28922637 0.84 S1PR1 (0.43) KMT2ATSHRMEN1ALOX15HSD17B10
SCHEMBL8128271 0.84 SLC1A1 (0.36) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL1606668 0.84 SLC1A1 (0.36) CYP1A2GRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112940162-B Synthetic method of highly-ordered dendritic heterogeneous sugar-containing polymer containing multiple glycosyl groups 上海应用技术大学 2023-02-10 CN claimed
WO-2021085967-A1 POLYSILOXANE COMPRISING TWO COATING LAYERS, AND PREPARATION METHOD THEREFOR 코스맥스 주식회사 2021-05-06 WO claimed
EP-4701443-A1 NUTRITIONAL COMPOSITION Société des Produits Nestlé S.A. (CH) 2026-03-04 EP disclosed
EP-4701444-A1 NUTRITIONAL COMPOSITION Société des Produits Nestlé S.A. (CH) 2026-03-04 EP disclosed
WO-2024227719-A1 NUTRITIONAL COMPOSITION Société des Produits Nestlé S.A. (CH) 2024-11-07 WO disclosed
WO-2024227720-A1 NUTRITIONAL COMPOSITION Société des Produits Nestlé S.A. (CH) 2024-11-07 WO disclosed
EP-3431605-B1 PUTRESCINE-PRODUCING MICROORGANISM AND METHOD FOR PRODUCING PUTRESCINE USING SAME CJ CHEILJEDANG CORP (KR) 2024-11-06 EP disclosed
US-20230392174-A1 MICROORGANISM FOR PRODUCING PUTRESCINE AND PROCESS FOR PRODUCING PUTRESCINE BY USING SAME CJ CHEILJEDANG CORPORATION (KR) 2023-12-07 US disclosed
CN-117098775-A Methods of treatment of AL amyloidosis 普罗塞纳生物科学有限公司 2023-11-21 CN disclosed
CN-112220797-B C/EBP alpha compositions and methods of use 米纳治疗有限公司 2023-11-03 CN disclosed
CN-116723852-A Method for treating diabetes 伊莱利利公司 2023-09-08 CN disclosed
EP-2806022-A1 RECOMBINANT MICROORGANISM WITH IMPROVED PUTRESCINE PRODUCTIVITY, AND METHOD FOR PRODUCING PUTRESCINE USING SAME Cj Cheiljedang Corporation (KR) 2014-11-26 EP disclosed
EP-2803721-A2 RECOMBINANT MICROORGANISM HAVING IMPROVED PUTRESCINE PRODUCING ABILITY AND METHOD FOR PRODUCING PUTRESCINE BY USING SAME Cj Cheiljedang Corporation (KR) 2014-11-19 EP disclosed
EP-2792354-A2 COMPOSITION OF PROTECTORS OF ACUTE AND CHRONIC HEPATIC ENCEPHALOPATHY AND METHOD FOR TREATING ACUTE AND CHRONIC HEPATIC ENCEPHALOPATHY Obshchestvo S Ogranichennoj Otvetstvennostju «Biotekhnologii Pyshchino» (RU) 2014-10-22 EP disclosed
US-20140004577-A1 MICROORGANISMS FOR PRODUCING PUTRESCINE AND METHOD FOR PRODUCING PUTRESCINE USING SAME CJ CHEILJEDANG CORPORATION (KR) 2014-01-02 US disclosed
US-20130344545-A1 MICROBES WITH AN IMPROVED ABILITY TO PRODUCE ORNITHINE AND METHOD FOR PRODUCING ORNITHINE USING SAME CJ CHELJEDANG CORPORATION (KR) 2013-12-26 US disclosed
EP-2650357-A2 MICROORGANISMS FOR PRODUCING PUTRESCINE AND METHOD FOR PRODUCING PUTRESCINE USING SAME CJ CheilJedang Corporation (KR) 2013-10-16 EP disclosed
EP-2650358-A2 MICROBES WITH AN IMPROVED ABILITY TO PRODUCE ORNITHINE AND METHOD FOR PRODUCING ORNITHINE USING SAME CJ CheilJedang Corporation (KR) 2013-10-16 EP disclosed
US-5679699-A ANTIISCHEMIC AGENTS, HEART RATE LOWERING AGENTS KALI-CHEMIE PHARMA GMBH (DE) 1997-10-21 US disclosed
US-5547967-A HYPOTENSIVE AGENT, ANTIISCHEMIC AGENT KALI-CHEMIE PHARMA GMBH (DE) 1996-08-20 US disclosed